Zomedica Corp.
ZOMDF
$0.10
$0.00-1.41%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 29.35% | 16.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.35% | 16.24% | |||
| Cost of Revenue | 24.14% | 15.71% | |||
| Gross Profit | 31.90% | 16.50% | |||
| SG&A Expenses | 4.22% | -5.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.35% | -1.99% | |||
| Operating Income | 21.83% | 17.78% | |||
| Income Before Tax | 22.74% | 16.87% | |||
| Income Tax Expenses | -1,026.32% | -258.33% | |||
| Earnings from Continuing Operations | 25.99% | 17.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.99% | 17.26% | |||
| EBIT | 21.83% | 17.78% | |||
| EBITDA | 30.98% | 23.03% | |||
| EPS Basic | 25.81% | 17.33% | |||
| Normalized Basic EPS | 23.08% | 17.02% | |||
| EPS Diluted | 25.81% | 17.33% | |||
| Normalized Diluted EPS | 23.08% | 17.02% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||